// STATE LEGISLATION TRACKER

Ohio HB 88: Regards drug trafficking, human trafficking, and fentanyl

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Passed chamber

State: Ohio
Bill: HB 88
Session: 136
Filed: 2025-02-11
Read the bill: OpenStates →
Last reviewed: 2026-10-05

Plain-English Summary

Ohio HB88 is a criminal justice and education bill focused on drug trafficking, human trafficking, fentanyl-related penalties, and fentanyl awareness instruction. Based on the title, subjects, and available status information, it does not appear to regulate compounded peptides, off-label prescribing, telehealth prescribing, NP or naturopathic scope, or FDA 503A/503B compounding.

Key Points

No clear change to access for prescribed or compounded peptides
No apparent change to telehealth prescribing rules
No apparent change to NP or naturopathic prescribing scope
Main effect is tougher treatment of fentanyl and drug trafficking offenses
Peptide users should watch only if a product involves controlled substances

What to Watch For

Note The bill is aimed at fentanyl, trafficking, sentencing, and education, not peptide prescribing or compounding.

Concern Any broad controlled-substance language could matter only if a product is tied to scheduled drugs or illegal distribution.

Note No clear signal that FDA 503A/503B pharmacy compounding rules are changed by this bill.

Where the Bill Stands

The bill passed the Ohio House on November 19, 2025 and was referred to the Senate Judiciary Committee on February 11, 2026.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws